Feasibility of Capturing Cancer Treatment Data in the Utah All-Payer Claims Database.
Journal
JCO clinical cancer informatics
ISSN: 2473-4276
Titre abrégé: JCO Clin Cancer Inform
Pays: United States
ID NLM: 101708809
Informations de publication
Date de publication:
10 2019
10 2019
Historique:
entrez:
23
11
2019
pubmed:
23
11
2019
medline:
30
5
2020
Statut:
ppublish
Résumé
Incompleteness of treatment data is a recognized limitation of cancer registry data. An all-payer claims database (APCD) is a tool that states use to capture health care information across systems and payer. We linked the Utah Cancer Registry (UCR) records to Utah's statewide APCD and evaluated how this linkage led to improvements in the capture of cancer treatment information. We linked cancers diagnosed and reported to the UCR with Utah APCD claims for the calendar years 2013 and 2014 using LinkPlus Software. For patients with breast or colorectal cancers, manual abstraction was completed to provide a gold-standard comparison for the treatment data obtained from the claims. Among 10,759 reportable cancer occurrences linked to the APCD, the claims identified additional patients with cancer who received therapies that had been unknown to the registry, increasing the proportion treated with chemotherapy from 23.7% to 27.6%, hormone therapy from 14.1% to 18.8%, immunotherapy from 4.3% to 13.2%, and radiation therapy from 24.9% to 27.5%. The APCD increased the sensitivity of treatment variables compared with the abstraction gold standard. Notably, sensitivity of hormonal therapy for breast cancer increased from 78.6% to 95.2% when augmented with APCD claims data. However, the APCD alone did not achieve as high specificity for treatment data as did the data collected through traditional registry methods. This is the first study, to our knowledge, showing that linking cancer registry data with a statewide claims database that covers multiple insurance companies improves cancer treatment data collection. Linking of cancer registry and APCD data can improve comprehensiveness of cancer registry treatment data.
Identifiants
pubmed: 31756128
doi: 10.1200/CCI.19.00027
pmc: PMC6882521
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
1-10Subventions
Organisme : FIC NIH HHS
ID : 26398D0016
Pays : United States
Organisme : NCI NIH HHS
ID : P30 CA042014
Pays : United States
Références
Oncology (Williston Park). 2009 Mar;23(3):288-95
pubmed: 19418830
Med Care. 2002 Aug;40(8 Suppl):IV-36-42
pubmed: 12187166
Med Care. 2002 Aug;40(8 Suppl):IV-43-8
pubmed: 12187167
Med Care. 1999 Nov;37(11):1105-15
pubmed: 10549613
J Clin Oncol. 2003 Jun 15;21(12):2232-3
pubmed: 12805320
Ann Intern Med. 2003 Nov 18;139(10):868; author reply 868-9
pubmed: 14623632
Health Serv Res. 2019 Jun;54(3):707-713
pubmed: 30675913
Med Care. 2016 Sep;54(9):e55-64
pubmed: 24638121
J Registry Manag. 2014 Summer;41(2):57-64
pubmed: 25153010
Cancer. 2012 Jan 15;118(2):333-41
pubmed: 21717446
J Surg Oncol. 2010 Jun 1;101(7):593-9
pubmed: 20461766
J Clin Oncol. 1997 Apr;15(4):1401-8
pubmed: 9193332
Med Care. 2003 Sep;41(9):1003-5
pubmed: 12972839
J Clin Oncol. 2003 Sep 15;21(18):3488-94
pubmed: 12972525
J Natl Cancer Inst. 2005 Oct 5;97(19):1407-27
pubmed: 16204691
Med Care. 2002 Aug;40(8 Suppl):IV-49-54
pubmed: 12187168
Med Care. 2002 Aug;40(8 Suppl):IV-55-61
pubmed: 12187169